![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
|
I'm concerned that the new version of this page may be too technical for the 'widest possible audience' aim of wikipedia. It reads like a scientific review article or thesis, rather than an encyclopedia. I'd like to hear the opinion of others. Viraltonic ( talk) 22:25, 21 April 2013 (UTC)
It seems to be the first OA and as data is added it will overwhelm the rest of the article ? - Rod57 ( talk) 10:58, 20 September 2013 (UTC)
Immunicum’s adenovirus technology gets green light for clinical study is about an adenovirus (Ad5PTDf35). Could go here or in oncolytic virus. Is splitting out adenoviruses useful or should we split oncolytic virus further ? - Rod57 ( talk) 03:06, 5 February 2016 (UTC)
![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
|
I'm concerned that the new version of this page may be too technical for the 'widest possible audience' aim of wikipedia. It reads like a scientific review article or thesis, rather than an encyclopedia. I'd like to hear the opinion of others. Viraltonic ( talk) 22:25, 21 April 2013 (UTC)
It seems to be the first OA and as data is added it will overwhelm the rest of the article ? - Rod57 ( talk) 10:58, 20 September 2013 (UTC)
Immunicum’s adenovirus technology gets green light for clinical study is about an adenovirus (Ad5PTDf35). Could go here or in oncolytic virus. Is splitting out adenoviruses useful or should we split oncolytic virus further ? - Rod57 ( talk) 03:06, 5 February 2016 (UTC)